Envestnet Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Envestnet Asset Management’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2	Closed	–	–	2867
2017 Q4	$0	Hold	2	–	–	﹤0.01%	2972
2017 Q3	$0	Hold	2	–	–	﹤0.01%	2945
2017 Q2	$0	Sell	2 -17	-89%	-$544	﹤0.01%	3066
2017 Q1	$1K	Sell	19 -8,764	-100%	-$273K	﹤0.01%	3051
2016 Q4	$294K	Sell	8,783 -507	-5%	-$14.5K	﹤0.01%	1723
2016 Q3	$247K	Sell	9,290 -6,365	-41%	-$148K	﹤0.01%	1928
2016 Q2	$345K	Sell	15,655 -1,398	-8%	-$36.6K	﹤0.01%	1826
2016 Q1	$501K	Buy	17,053 +1,562	+10%	+$43.5K	﹤0.01%	1631
2015 Q4	$512K	Buy	15,491 +2,270	+17%	+$74K	﹤0.01%	1577
2015 Q3	$478K	Buy	13,221 +2,599	+24%	+$112K	﹤0.01%	1621
2015 Q2	$478K	Buy	10,622 +2,924	+38%	+$114K	﹤0.01%	1737
2015 Q1	$236K	Buy	+7,698	New	+$300K	﹤0.01%	1890

Other funds holding ENTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Envestnet Asset Management's ENTA Position: Q1 2018 in Review

Envestnet Asset Management sold out of Enanta Pharmaceuticals (ENTA) in Q1 2018, closing a stake of 2 shares.

Envestnet Asset Management first reported a position in ENTA in Q1 2015 and held it in 12 quarters. The position peaked at $512K in Q4 2015. 181 funds tracked by Wall St. Rank hold ENTA as of Q1 2018.

Envestnet Asset Management reported no remaining Enanta Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Envestnet Asset Management sold 2 Enanta Pharmaceuticals shares in Q1 2018.
Envestnet Asset Management first reported a position in Enanta Pharmaceuticals in Q1 2015 and held it in 12 quarters.
Envestnet Asset Management's Enanta Pharmaceuticals position peaked at $512K in Q4 2015.
181 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2018.

Based on Envestnet Asset Management's 13F filing for Q1 2018, filed 9 May 2018.